PREVIEW: ASCO in Action CEO & CMO Interview
ASCO Guidelines19 Jan 2021

PREVIEW: ASCO in Action CEO & CMO Interview

A preview of the interview by ASCO in Action podcast host ASCO CEO Dr. Clifford A. Hudis with retiring ASCO Chief Medical Officer Dr. Richard L. Schilsky examining Dr. Schilsky's trailblazing medical career, his leadership in ASCO and indelible mark on its research enterprise, and what he sees for the future of oncology. Dr. Hudis also shares what Dr. Schilsky's friendship and mentorship has meant to him and suggests that he will still be supporting ASCO on critical priorities. Find all nine of ASCO's podcasts and subscribe at podcast.asco.org.

TRANSCRIPT

Dr. Clifford Hudis: Hello, I'm Dr. Clifford Hudis, CEO of ASCO, dropping into your feed to let you know about a special episode of the ASCO in Action podcast featuring the extraordinary career of Dr. Richard Schilsky, ASCO's Chief Medical Officer. Rich and I discuss the advances that have revolutionized cancer care over the last 50 years and much, much more. Here's a preview of the episode.


Dr. Richard Schilsky: The 1980s in many respects were the doldrums of progress in clinical oncology. There really was not a lot of innovation in the clinic. But what was happening and what was invisible to many of us, of course, was that was the decade of discovery of the fundamental biology of cancer. That's when oncogenes were discovered, when tumor suppressor genes were discovered, when it became clear that cancer was really a genetic disease. And that is what transformed the field and put us on the path to targeted therapy and precision medicine as we think of it today.


Dr. Clifford Hudis: You can find the ASCO in Action Podcast on Apple Podcasts or wherever you are listening to this show. And you can find all nine of ASCO's podcasts which cover a wide range of educational and scientific content and offer enriching insight of the world of cancer care at podcast.asco.org.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(200)

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.2

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.2

Dr. Sonam Puri joins the podcast to share the update to the living guideline on stage IV NSCLC with driver alterations. Dr. Puri discusses the practice-changing evidence reviewed for both NTRK rearran...

28 Juli 9min

Treatment of Multiple Myeloma: ASCO Living Guideline Update 2026.1.1

Treatment of Multiple Myeloma: ASCO Living Guideline Update 2026.1.1

Dr. Rahul Banerjee joins the podcast to discuss the latest update to the living guideline on the treatment of multiple myeloma. He explains how sensational results from the MajesTEC-3 trial, which eva...

29 Juni 17min

Circulating Tumor DNA Testing in Solid Tumors and Lymphoma Guideline

Circulating Tumor DNA Testing in Solid Tumors and Lymphoma Guideline

Drs. Tina Lockwood and Stacy Gray share the newly released evidence-based guideline on circulating tumor DNA (ctDNA) testing from ASCO. They highlight recommendations on when ctDNA testing should be o...

18 Juni 17min

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 2

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 2

Dr. Joshua Reuss returns to the podcast to discuss the update to the living guideline on stage IV NSCLC with driver alterations. The conversation focuses on new cancer treatment strategies for patient...

26 Maj 19min

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 1

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 1

Dr. Lyudmila Bazhenova joins the podcast to share the update to the living guideline on stage IV NSCLC without driver alterations. Dr. Bazhenova discusses the evidence reviewed for both non-squamous N...

26 Maj 13min

Systemic Treatment of Thyroid Cancer Guideline

Systemic Treatment of Thyroid Cancer Guideline

Dr. Nabil Saba shares the first evidence-based guideline on thyroid cancer from ASCO. He highlights recommendations on first- and subsequent-line systemic treatment – including multikinase inhibitors ...

1 Apr 23min

Patient-Clinician Communication Guideline Update

Patient-Clinician Communication Guideline Update

Dr. Timothy Gilligan and Dr. Calvin Chou discuss the updated guideline on patient-clinician communication in oncology. They highlight clinical recommendations and strategies on topics such as communic...

10 Mars 31min

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Guideline Update

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Guideline Update

Dr. Lakshmi Rajdev and Dr. Manish Shah join the podcast to discuss the updated guideline on immunotherapy and targeted therapy in unresectable locally advanced, advanced, or metastatic gastroesophagea...

26 Feb 28min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
bullfika
inga-beiga-morsor
rss-vuxna-pa-latsas
sexnoveller-deluxe
not-fanny-anymore
angestpodden
johannes-hansen-podcast
rss-viktmedicinpodden
sa-in-i-sjalen
rss-angra-inget-3
rss-autismandan
hacka-livet
rss-basta-livet
sova-med-dan-horning
tyngre-radio
rss-hos-psykologen
rss-traningsklubben
tyngre-traningssnack